Form RW CS DIAGNOSTICS CORP.

 

 

U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549

July 24, 2025

 

Electronically filed through EDGAR

 

Re: CS Diagnostics, Corp. (CSDX) Form 10-12G (File No. 000-29611)

 

Dear Sir or Madam:

 

Pursuant to the Securities Exchange Act of 1934, as amended (the “Securities Act”), CS Diagnostics, Corp. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of its Form 10-12G filing (File No. 000-29611), filed on July 22, 2025, together with all exhibits and amendments thereto (collectively, the “Information Statement”).

 

The Company intends to amend and update its Information Statement and will re-submit a revised registration form to the Commission. This withdrawal request aims to avoid any potential confusion and to ensure that the Commission and the investing public receive accurate and current information.

 

If you have any questions with respect to the foregoing, please call Wendy Culbertson of Mavacy, PLLC at 602-706-1336.

 

 

 

Respectfully submitted,

 

 

 

Mohammad EsSayed

Group Chief Financial Officer

 

 

 

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order
• DNA My Dog Expands Product Suite With Launch of New Health and Trait Test, Building on 18-Year Foundation in Canine Genetic Testing
• Hypercharge Announces Issuance of Option Grants